Citi analyst Ralph Giacobbe reiterated a Neutral rating and $145.00 price target on Quest Diagnostics (NYSE: DGX).The analyst comments "Earlier ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE